Evidence map›Paper›PMID 34503255›Full record

ReviewCancers2021

Photodynamic Therapy: A Compendium of Latest Reviews.

José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, Luís Rodríguez-Cobo, José Miguel López-Higuera

Abstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. ECgo: All-optical induction of single endothelial cell injury and capillary occlusion in the brain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Natural Chlorin eACS omega · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

José Francisco AlgorriPhotonics Engineering Group, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0002-2654-583X
Mario OchoaPhotonics Engineering Group, University of Cantabria, 39005 Santander, Spain.
Pablo Roldán-VaronaPhotonics Engineering Group, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0002-4263-8243
Luís Rodríguez-CoboCIBER-bbn, Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-2068-2956
José Miguel López-HigueraPhotonics Engineering Group, University of Cantabria, 39005 Santander, Spain.

Funding

Ministerio de Ciencia, Tecnología e Innovación Productiva PID2019-107270RB-C21/AIE/10.13039/501100011033
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a promising therapy against cancer. Even though it has been investigated for more than 100 years, scientific publications have grown exponentially in the last two decades. For this reason, we present a brief compendium of reviews of the last two decades classified under different topics, namely, overviews, reviews about specific cancers, and meta-analyses of photosensitisers, PDT mechanisms, dosimetry, and light sources. The key issues and main conclusions are summarized, including ways and means to improve therapy and outcomes. Due to the broad scope of this work and it being the first time that a compendium of the latest reviews has been performed for PDT, it may be of interest to a wide audience.

Indexed as

cancermeta-analysisoverviewphotodynamic therapyreview

Identifiers

PMID34503255
PMCPMC8430498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.